Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Peri-adventitial SMA Dissection on Margin Status During Pancreaticoduodenectomy for Resectable Pancreatic Cancer

NCT04902352 is registered in ClinicalTrials.gov with University Hospital Birmingham NHS Foundation Trust as lead sponsor.

NCT NCT04902352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04902352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Peri-adventitial SMA Dissection on Margin Status During Pancreaticoduodenectomy for Resectable Pancreatic Cancer
Lead sponsor
University Hospital Birmingham NHS Foundation Trust
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 6, 2021
Completion date
October 6, 2026
Enrollment
102 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic adenocarcinoma